Literature DB >> 5139563

Urinary metabolites of the antitumor agent cyclophosphamide.

R F Struck, M C Kirk, L B Mellett, S el Dareer, D L Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5139563

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  21 in total

1.  Basic principles in preclinical cancer chemotherapy.

Authors:  N Brock; J Pohl; B Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide.

Authors:  E J Valente; K K Chan; K L Servis
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

3.  The effect of route of administration and fractionation of dose on the metabolism of ifosfamide.

Authors:  M J Lind; H L Roberts; N Thatcher; J R Idle
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

Review 5.  [Metabolic pathways of cyclophosphamide].

Authors:  K Norpoth; H M Rauen
Journal:  Klin Wochenschr       Date:  1972-05-01

6.  Formation of 4-ketocyclophosphamide by the oxidation of cyclophosphamide with KMnO4.

Authors:  M Jarman
Journal:  Experientia       Date:  1973

7.  The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide.

Authors:  M C Berenbaum; W A Cope; J A Double
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

8.  Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.

Authors:  Fei Li; Andrew D Patterson; Constance C Höfer; Kristopher W Krausz; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

9.  Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokinetic study.

Authors:  R N Harris; P J Basseches; P L Appel; A M Durski; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 10.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.